List of SBIR/STTR awards granted to GLC Biotechnology, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to GLC Biotechnology, Inc. in August, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA232914-01 | Phase I | 225,000 | August 14, 2018 | |||||||
A SBIR Phase II contract was awarded to GLC Biotechnology, Inc. in September, 2019 for $750,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM134758-01 | Phase II | 750,000 | September 9, 2019 | |||||||
A SBIR Phase I contract was awarded to GLC Biotechnology, Inc. in June, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM117698-01A1 | Phase I | 225,000 | June 1, 2016 | |||||||
A SBIR Phase I contract was awarded to GLC Biotechnology, Inc. for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA183170-01A1 | Phase I | 225,000 | ||||||||
A SBIR Phase I contract was awarded to GLC Biotechnology, Inc. for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HG003422-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to GLC Biotechnology, Inc. for $1,799,300.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA134258-02 | Phase II | 1,799,300 | ||||||||
A SBIR Phase II contract was awarded to GLC Biotechnology, Inc. for $1,342,960.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44CA121932-02 | Phase II | 1,342,960 | ||||||||
A SBIR Phase I contract was awarded to GLC Biotechnology, Inc. for $145,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA118340-01 | Phase I | 145,000 | ||||||||
A SBIR Phase I contract was awarded to GLC Biotechnology, Inc. for $219,350.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA134258-01 | Phase I | 219,350 | ||||||||
A SBIR Phase II contract was awarded to GLC Biotechnology, Inc. in September, 2023 for $1,071,571.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA284965-01 | Phase II | 1,071,571 | September 18, 2023 |
